Processa Pharmaceuticals, Inc. (PCSA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-10.36 | +89.3% |
| 2024 | $-96.78 | -1041.3% |
| 2023 | $-8.48 | +75.1% |
| 2022 | $-34.05 | -4440.0% |
| 2021 | $-0.75 | — |
| 2017 | $-0.06 | +14.3% |
| 2016 | $-0.07 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-10.36 | +89.3% |
| 2024 | $-96.78 | -1041.3% |
| 2023 | $-8.48 | +75.1% |
| 2022 | $-34.05 | -4440.0% |
| 2021 | $-0.75 | — |
| 2017 | $-0.06 | +14.3% |
| 2016 | $-0.07 | — |